Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada (NCT07249489)
A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions
🩺 Plain-English Summary (8th-Grade Level)
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Who can join: Review the eligibility criteria below.
Location: University of British Columbia — Vancouver, British Columbia
Age range: 22 Years to 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of British Columbia — Vancouver, British Columbia
- Orthopaedic Clinic — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (615) 483-7438
Email: Heather@Nanochon.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Knee Cartilage Lesions
- Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama — Panama City, Provincia de Panamá
Explore by condition: All Knee Cartilage Lesions clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.